Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (61-70 of 551) with videos related to

Pageof 56
Sort By:
Preventive Medicine|September 1, 1989
Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neckS M Lippman, H S Garewal, F L Meyskens
The American Journal of Medicine|September 1, 1987
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potentialA C Buzaid, S M Lippman, T P Miller
Cancer Treatment Reports|April 1, 1987
Retinoids as preventive and therapeutic anticancer agents (Part I)S M Lippman, J F Kessler, F L Meyskens
Preventive Medicine|September 1, 1993
Retinoids in chemoprevention of head and neck carcinogenesisS M Lippman, S E Benner, W K Hong
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
Selenium effects on prostate cell growthD G Menter, A L Sabichi, S M Lippman
Cancer|August 1, 1993
Chemoprevention. Strategies for the control of cancerS M Lippman, S E Benner, W K Hong
Oncology (Williston Park, N.Y.)|August 1, 1992
Current status of chemoprevention of head and neck cancerS E Benner, S M Lippman, W K Hong
Seminars in Hematology|October 1, 1994
Retinoid chemoprevention of second primary tumorsS E Benner, S M Lippman, W K Hong
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapyLibero Santarpia, Scott M Lippman, Adel K El-Naggar
Topics in Current Chemistry|August 2, 2012
Natural-agent mechanisms and early-phase clinical developmentJanet L Wang, Kathryn A Gold, Scott M Lippman
Pageof 56

Showing results (61-70 of 551) with videos related to

Sort By:
Pageof 56
Preventive Medicine|September 1, 1989
Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neckS M Lippman, H S Garewal, F L Meyskens
The American Journal of Medicine|September 1, 1987
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potentialA C Buzaid, S M Lippman, T P Miller
Cancer Treatment Reports|April 1, 1987
Retinoids as preventive and therapeutic anticancer agents (Part I)S M Lippman, J F Kessler, F L Meyskens
Preventive Medicine|September 1, 1993
Retinoids in chemoprevention of head and neck carcinogenesisS M Lippman, S E Benner, W K Hong
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
Selenium effects on prostate cell growthD G Menter, A L Sabichi, S M Lippman
Cancer|August 1, 1993
Chemoprevention. Strategies for the control of cancerS M Lippman, S E Benner, W K Hong
Oncology (Williston Park, N.Y.)|August 1, 1992
Current status of chemoprevention of head and neck cancerS E Benner, S M Lippman, W K Hong
Seminars in Hematology|October 1, 1994
Retinoid chemoprevention of second primary tumorsS E Benner, S M Lippman, W K Hong
Expert Opinion on Therapeutic Targets|January 14, 2012
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapyLibero Santarpia, Scott M Lippman, Adel K El-Naggar
Topics in Current Chemistry|August 2, 2012
Natural-agent mechanisms and early-phase clinical developmentJanet L Wang, Kathryn A Gold, Scott M Lippman
Pageof 56